VIVIMEDLAB

Vivimed Labs Share Price

 
Stock touched 52W low

 

Start SIP in VIVIMEDLAB

Start SIP
Vivimed Labs live price: ₹5.55. It opened at ₹6 vs previous close ₹6; intraday high/low: ₹6/₹6. The 50 & 200 DMA stand at ₹7.75/₹10.03.

Vivimed Labs Performance

  • Today's Low
  • ₹6
  • Today's High
  • ₹6
  • 52 Week Low
  • ₹6
  • 52 Week High
  • ₹29
  • Open Price₹6
  • Previous Close₹6
  • Volume191,089
  • 50 DMA₹7.75
  • 100 DMA₹8.73
  • 200 DMA₹10.03

Investment Returns

  • Over 1 Month -26.2%
  • Over 3 Month -73.05%
  • Over 6 Month + 455%
  • Over 1 Year + 455%

Smart Investing Starts Here Start SIP with Vivimed Labs for Steady Growth!

Invest Now

Vivimed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -1.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 46
  • P/B Ratio
  • -0.6
  • Average True Range
  • 0.41
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.49
  • RSI
  • 30.91
  • MFI
  • 24.23

Vivimed Labs Financials

Vivimed Labs Technicals

EMA & SMA

Current Price
₹5.55
-0.29 (-4.97%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹6.71
  • 50 Day
  • ₹7.75
  • 100 Day
  • ₹8.73
  • 200 Day
  • ₹10.03

Resistance and Support

5.89 Pivot Speed
  • R3 6.23
  • R2 6.13
  • R1 5.99
  • S1 5.75
  • S2 5.65
  • S3 5.51

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivimed Labs has an operating revenue of Rs. 83.60 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of -27% needs improvement, NULL From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D which indicates heavy supply, Group Rank of 38 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivimed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-03-13 Quarterly Results
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results, Pref. issue & A.G.M.
2025-05-30 Audited Results
2025-02-14 Quarterly Results

Vivimed Labs F&O

Vivimed Labs Shareholding Pattern

7.77%
0%
0%
1.64%
0%
65.06%
25.53%

Vivimed Labs FAQs

Vivimed Labs share price is ₹5 As on 27 March, 2026 | 15:30

The Market Cap of Vivimed Labs is ₹46 Cr As on 27 March, 2026 | 15:30

The P/E ratio of Vivimed Labs is -1.3 As on 27 March, 2026 | 15:30

The PB ratio of Vivimed Labs is -0.6 As on 27 March, 2026 | 15:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23